Update
$Cingulate(CING.US$ Reuters· 1 min ago
Cingulate Achieves Key Manufacturing Milestone in the Development of Its Adhd Drug Ctx-1301 in Preparation for FDA Marketing Clearance
Cingulate Achieves Key Manufacturing Milestone in the Development of Its Adhd Drug Ctx-1301 in Preparation for FDA Marketing Clearance
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
JESSE JAMES8832 : been waiting on this
JESSE JAMES8832 : hope it doesn't get shorted to shit
TrytosaveabitOP JESSE JAMES8832: Yeah but I don’t think they are submitting marketing application until 2025?
TrytosaveabitOP JESSE JAMES8832: Yeah but like a lot I’m always watching for that! Grrrr
_Max_ : $1